Tag Archives: CureVac

CureVac COVID-19 Vaccine Induces Immune Response in Early Trial

Berlin, November 2: German vaccine maker CureVac on Monday said that interim results from early trials showed that its investigational Covid-19 vaccine candidate, CvnCoV, appeared safe and triggered immune response among volunteers. The vaccine candidate was generally well tolerated across all tested doses and induced strong binding and neutralising antibody responses in addition to first… Read More »